1d:I[2890,["266","static/chunks/870fdd6f-4fcc92c129a57d11.js","970","static/chunks/970-91a3a37cc668faba.js","857","static/chunks/857-3b2a1421afa266d2.js","965","static/chunks/app/podcasts/episode/%5BpodcastEpisodeGuid%5D/page-e939c6b91b4a25d4.js"],"default"] 1e:I[1318,["266","static/chunks/870fdd6f-4fcc92c129a57d11.js","970","static/chunks/970-91a3a37cc668faba.js","857","static/chunks/857-3b2a1421afa266d2.js","965","static/chunks/app/podcasts/episode/%5BpodcastEpisodeGuid%5D/page-e939c6b91b4a25d4.js"],"default"] 1f:T5c6,

A month ago, I had the privilege of visiting Beond in Cancun, Mexico to experience an ibogaine treatment for cognitive enhancement. Today, I’m joined by Beond CEO Tom Feegel to discuss how this remarkable medicine can support a better brain.

In this episode, we explore Tom’s personal journey with Ibogaine, its potential to revolutionize addiction treatment, and how it supports cognitive enhancement. We discuss key safety concerns, the importance of integrity in healing, and Tom’s reflections on this transformative medicine. Finally, we look ahead to the future of psychedelic access and its impact on mental health worldwide.
Tom Feegel is co-founder of Beond Ibogaine, an ibogaine-assisted treatment and research center in Mexico for trauma, PTSD, addiction, and health optimization. He was previously CEO of EO Products, and a founding executive at Brandless. A father of five, Tom lives in Mexico and continues to push boundaries in mental health and addiction recovery.

Timestamps

06:25 Tom’s Personal Journey with Ibogaine 10:25 Ibogaine's Impact on Cognitive Enhancement 17:42 Safety Concerns and Proper Use of Ibogaine 27:53 Clinical Environment vs. Shamanic Experience 36:20 Cognitive Enhancement with Ibogaine: Latest Research 40:38 Who Should Consider Ibogaine Therapy? 50:25 The Importance of Integrated Healing 56:41 Access and Inequality in Psychedelic Therapy

Links

‌

Episode description

Tom Feegel: Ibogaine for Cognitive Enhancement

Episode description